Symplast, a mobile EHR/Practice Management software for plastic surgery and medical spas that according to the company delivers a HIPAA-secure cloud platform to more than 3,500 aesthetic users across the U.S., is reporting record increases in customer demand, activations and telehealth feature usage as a result of the demand for telemedicine during the COVID-19 pandemic.

The crisis has also brought Symplast to the forefront of the aesthetic industry as the definitive thought leader regarding telehealth, and in particular, the critical understanding that telehealth is not simply just a virtual consultation; but rather a multi-pronged array of HIPAA secure touchpoints such as texting, standardized videos, and multimedia file sharing, it reports.